XML 23 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Total Itron, Inc. Shareholders' Equity
Common Stock
Common Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Noncontrolling Interests
Balance (in shares) at Dec. 31, 2021     45,152        
Balance (value) at Dec. 31, 2021 $ 1,142,759 $ 1,116,077   $ 1,779,775 $ (148,098) $ (515,600) $ 26,682
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (9,547) (9,732)       (9,732) 185
Other comprehensive income (loss), net of tax 53,424 53,424     53,424   0
Distributions to noncontrolling interests (3,784) 0         (3,784)
Options exercised (in shares)     1        
Options exercised (value) 30 30   30      
Restricted stock awards released (in shares)     227        
Restricted stock awards released (value) 0 0   0      
Issuance of stock-based compensation awards (in shares)     16        
Issuance of stock-based compensation awards (value) 952 952   952      
Employee stock purchase plan (in shares)     70        
Employee stock purchase plan (value) 3,422 3,422   3,422      
Stock-based compensation expense 20,929 20,929   20,929      
Stock repurchased during period, shares     (280)        
Stock Repurchased During Period, Value (16,629) (16,629)   (16,629)      
Balance (in shares) at Dec. 31, 2022     45,186        
Balance (value) at Dec. 31, 2022 1,191,556 1,168,473   1,788,479 (94,674) (525,332) 23,083
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 98,318 96,923       96,923 1,395
Other comprehensive income (loss), net of tax 13,484 13,484     13,484   0
Distributions to noncontrolling interests (3,958) 0         (3,958)
Options exercised (in shares)     18        
Options exercised (value) 830 830   830      
Restricted stock awards released (in shares)     242        
Restricted stock awards released (value) 0 0   0      
Issuance of stock-based compensation awards (in shares)     15        
Issuance of stock-based compensation awards (value) 1,065 1,065   1,065      
Employee stock purchase plan (in shares)     51        
Employee stock purchase plan (value) 2,844 2,844   2,844      
Stock-based compensation expense $ 27,292 27,292   27,292      
Balance (in shares) at Dec. 31, 2023 45,512   45,512        
Balance (value) at Dec. 31, 2023 $ 1,331,431 1,310,911   1,820,510 (81,190) (428,409) 20,520
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 241,124 239,105       239,105 2,019
Other comprehensive income (loss), net of tax (28,741) (28,741)     (28,741)   0
Distributions to noncontrolling interests (1,711) 0         (1,711)
Options exercised (in shares)     89        
Options exercised (value) 4,558 4,558   4,558      
Restricted stock awards released (in shares)     446        
Restricted stock awards released (value) (4) (4)   (4)      
Issuance of stock-based compensation awards (in shares)     13        
Issuance of stock-based compensation awards (value) 1,343 1,343   1,343      
Employee stock purchase plan (in shares)     43        
Employee stock purchase plan (value) 3,767 3,767   3,767      
Stock-based compensation expense 42,531 42,531   42,531      
Payments on call spread for convertible offering, net of tax (82,304) (82,304)   (82,304)      
Stock repurchased during period, shares     (972)        
Stock Repurchased During Period, Value (100,000) (100,000)   (100,000)      
Registration fee (54) (54)   (54)      
Excise tax related to shares repurchased $ (512) (512)   (512)      
Balance (in shares) at Dec. 31, 2024 45,131   45,131        
Balance (value) at Dec. 31, 2024 $ 1,411,428 $ 1,390,600   $ 1,689,835 $ (109,931) $ (189,304) $ 20,828